Literature DB >> 21929869

B7-H4 induces donor-specific tolerance in mouse islet allografts.

Xiaojie Wang1, Jianqiang Hao, Daniel L Metzger, Alice Mui, Ziliang Ao, C Bruce Verchere, Lieping Chen, Dawei Ou, Garth L Warnock.   

Abstract

Negative cosignaling molecules play an important role in regulating T-cell responses to alloantigen stimulation. We recently reported that adenoviral-mediated transduction of islet allografts with B7-H4 inhibits allograft rejection. In this study, we investigate the mechanism for B7-H4-induced prolongation of mouse islet allograft survival. Streptozotocin-induced diabetic C57BL/6 mice were rendered normoglycemic by renal subcapsular implants of B7-H4-transduced BALB/c islets. Grafts and spleens were removed after days 2, 10, and 60 (n = 8 each) for characterization of kinetics of Foxp3 and interleukin 10 (IL-10) expression. Mixed lymphocyte reaction (MLR) was done at day 60. Ten mice were subjected to nephrectomy at 60 days and then five were implanted with secondary BALB/c islets and five were given third-party CBA/J islets. An increase in Foxp3 and IL-10 mRNA expression was detected in recipients' spleens at day 60 and this was associated with increased quantities of Foxp3(+) cells. Splenocytes at day 60 showed hyporesponsiveness during MLR to alloantigen stimulation. Proliferation was partially restored after CD25(+) T-cell depletion. Secondary BALB/c islets survived for 79 ± 29 days compared with 21 ± 3.6 days for CBA/J islets (p < 0.001). Local expression of B7-H4 induces long-term unresponsiveness to donor-specific alloantigens, and is associated with T regulatory cells, suggesting the development of tolerance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21929869     DOI: 10.3727/096368911X582750

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  10 in total

1.  Blockade of both B7-H4 and CTLA-4 co-signaling pathways enhances mouse islet allograft survival.

Authors:  Xiaojie Wang; Jianqiang Hao; Daniel L Metzger; Alice Mui; I-Fang Lee; Noushin Akhoundsadegh; C Lieping Chen; Dawei Ou; Ziliang Ao; C Bruce Verchere; Garth L Warnock
Journal:  Islets       Date:  2012-07-01       Impact factor: 2.694

Review 2.  B7-H4 as a protective shield for pancreatic islet beta cells.

Authors:  Annika C Sun; Dawei Ou; Dan S Luciani; Garth L Warnock
Journal:  World J Diabetes       Date:  2014-12-15

3.  B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms.

Authors:  Joseph R Podojil; Linda N Liu; Shannon A Marshall; Ming-Yi Chiang; Gwen E Goings; Lieping Chen; Solomon Langermann; Stephen D Miller
Journal:  J Autoimmun       Date:  2013-05-14       Impact factor: 7.094

4.  Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes.

Authors:  Ilian A Radichev; Lilia V Maneva-Radicheva; Christina Amatya; Maryam Salehi; Camille Parker; Jacob Ellefson; Paul Burn; Alexei Y Savinov
Journal:  J Immunol       Date:  2016-01-15       Impact factor: 5.422

Review 5.  B7-H4's role "beyond the tumor".

Authors:  Ning Yu; Xiaomei Li; Songguo Zheng; Xiangpei Li
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

6.  Long-term survival of allograft murine islets coated via covalently stabilized polymers.

Authors:  Hernán R Rengifo; Jaime A Giraldo; Irayme Labrada; Cherie L Stabler
Journal:  Adv Healthc Mater       Date:  2014-02-05       Impact factor: 9.933

7.  B7x/B7-H4 modulates the adaptive immune response and ameliorates renal injury in antibody-mediated nephritis.

Authors:  R D Pawar; B Goilav; Y Xia; L Herlitz; J Doerner; S Chalmers; K Ghosh; X Zang; C Putterman
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

Review 8.  B7 family checkpoint regulators in immune regulation and disease.

Authors:  Sabrina Ceeraz; Elizabeth C Nowak; Randolph J Noelle
Journal:  Trends Immunol       Date:  2013-08-13       Impact factor: 16.687

9.  B7-H4 Pathway in Islet Transplantation and β-Cell Replacement Therapies.

Authors:  Xiaojie Wang; Jianqiang Hao; Daniel L Metzger; Ziliang Ao; Mark Meloche; C Bruce Verchere; Lieping Chen; Dawei Ou; Alice Mui; Garth L Warnock
Journal:  J Transplant       Date:  2011-10-13

10.  MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY.

Authors:  Therese Liechtenstein; Ines Dufait; Alessio Lanna; Karine Breckpot; David Escors
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2012-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.